Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy
In this study, a survival score was developed based on PD patterns. The risk classification was associated with PPOS across various solid tumors treated with immunotherapy and may therefore enhance prognostication and clinical decision-making, potentially providing a valuable tool for treating patients with PD who are receiving immunotherapy.
Authors
- Viktor Grünwald (ORCID: https://orcid.org/0000-0003-2083-7687)
- Michael Hölzel (ORCID: https://orcid.org/0000-0003-4048-8824)
- Julian Alexander Luetkens (ORCID: https://orcid.org/0000-0002-7715-4636)
- Manuel Ritter (ORCID: https://orcid.org/0000-0003-0619-0370)
- Jörg Ellinger (ORCID: https://orcid.org/0000-0002-7526-0857)
- Jonas Saal (ORCID: https://orcid.org/0000-0002-9647-2947)
- Peter Brossart
- Niklas Klümper (ORCID: https://orcid.org/0000-0002-3258-0586)
- Markus Eckstein (ORCID: https://orcid.org/0000-0001-5418-3349)
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Bonn (DE)
- Universitätsklinikum Erlangen (DE)
- Essen University Hospital (DE)
- Comprehensive Cancer Center Erlangen (DE)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1001/jamaoncol.2024.5672
- Citations
- 14
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.96